Literature DB >> 22015717

Stimulation of α(2A)-adrenoceptors promotes the maturation of dendritic spines in cultured neurons of the medial prefrontal cortex.

Wen-Wen Ren1, Yue Liu, Bao-Ming Li.   

Abstract

Dendritic spines are tiny protrusions along dendrites that receive excitatory synaptic inputs and compartmentalize postsynaptic responses in the mature brain. It is known that change in spine morphology is associated with brain functions such as learning and memory. α(2A)-Adrenoceptors (α(2A)-ARs) are highly expressed in cortical neurons and play important roles in neuronal differentiation, growth and neurotrophy. However, little is known about the role of α(2A)-ARs in the maturation of dendritic spines. Here, we report that stimulation of α(2A)-ARs promotes the maturation of dendritic spines in cultured neurons of the medial prefrontal cortex of rodents. Our results show that, stimulation of α(2A)-ARs by guanfacine induced significantly more stubby or mushroom spines in cultured mPFC neurons, with an enlargement of the spine head size. In parallel, the expression of PSD95 (a postsynaptic protein) in guanfacine-treated neurons was enhanced, while that of synapsin (a pre-synaptic protein) kept unchanged. These effects of guanfacine were blocked by co-administered yohimbine, a non-selective α(2)-AR antagonist. The present results implicate a prominent role of α(2A)-ARs in regulating the maturation of dendritic spines in the mPFC.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015717     DOI: 10.1016/j.mcn.2011.10.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  9 in total

Review 1.  Dendritic spine pathology in schizophrenia.

Authors:  J R Glausier; D A Lewis
Journal:  Neuroscience       Date:  2012-04-27       Impact factor: 3.590

2.  Modulation of Monoaminergic Systems by Antidepressants in the Frontal Cortex of Rats After Chronic Mild Stress Exposure.

Authors:  David Martín-Hernández; Marta P Pereira; Hiram Tendilla-Beltrán; José L M Madrigal; Borja García-Bueno; Juan C Leza; Javier R Caso
Journal:  Mol Neurobiol       Date:  2019-05-03       Impact factor: 5.590

Review 3.  Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders.

Authors:  Amy F T Arnsten; Min Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

4.  Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic Stress.

Authors:  Avis Brennan Hains; Yoko Yabe; Amy F T Arnsten
Journal:  Neurobiol Stress       Date:  2015

5.  Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.

Authors:  Amy F T Arnsten
Journal:  Neurobiol Learn Mem       Date:  2020-10-17       Impact factor: 2.877

Review 6.  Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.

Authors:  Michael Huss; Wai Chen; Andrea G Ludolph
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

7.  Adolescent cocaine self-administration induces habit behavior in adulthood: sex differences and structural consequences.

Authors:  L M DePoy; A G Allen; S L Gourley
Journal:  Transl Psychiatry       Date:  2016-08-30       Impact factor: 6.222

8.  Altered Behavior in Mice Socially Isolated During Adolescence Corresponds With Immature Dendritic Spine Morphology and Impaired Plasticity in the Prefrontal Cortex.

Authors:  William E Medendorp; Eric D Petersen; Akash Pal; Lina-Marie Wagner; Alexzander R Myers; Ute Hochgeschwender; Kenneth A Jenrow
Journal:  Front Behav Neurosci       Date:  2018-05-09       Impact factor: 3.558

Review 9.  Impact of Pharmacological and Non-Pharmacological Modulators on Dendritic Spines Structure and Functions in Brain.

Authors:  Arehally M Mahalakshmi; Bipul Ray; Sunanda Tuladhar; Tousif Ahmed Hediyal; Praveen Raj; Annan Gopinath Rathipriya; M Walid Qoronfleh; Musthafa Mohamed Essa; Saravana Babu Chidambaram
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.